New agreement signed with i2020 to tackle neurological diseases
We are delighted to announce that that we have another agreement signed with i2020 accelerator, following on from the one in 2019. This supports our group’s efforts to identify and develop strategies for neurological diseases with no or inadequate treatments by targeting NOS1AP.
Last updated on March 5, 2025
Recent Posts
- Rector Widen Visited Our Centre Åbo Akademi University Rector, Gunilla Widén, visited our Centre on Wednesday, February 25th, to learn Read moreFebruary 27, 2026
- Laura Elo is awarded the Leif C. Groop Award for outstanding research on type 1 diabetesLaura Elo a group leader at Turku Bioscience is awarded the Leif C. Groop Award Read moreFebruary 23, 2026
- Finnish Cultural Foundation Awards Funding to Turku Bioscience ResearchersWe are pleased to announce recent funding from The Finnish Cultural Foundation: Congratulations to all Read moreFebruary 16, 2026
- Newly discovered gut microbial molecules in infancy may influence the risk of type 1 diabetesAn international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important Read moreJanuary 20, 2026
- Turku Bioscience Centre Is Recruiting New Research LeadersTurku Bioscience Centre is currently inviting applications for two key research positions that will strengthen Read moreJanuary 13, 2026
- Season’s Greetings & Happy 2026!Season’s Greetings & Happy 2026! From everyone at Turku Bioscience. Riitta Lahesmaa,Director of Turku Bioscience Read moreDecember 23, 2025